Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Aarhus Osteopati Klinikker ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.0% 11.1% 11.9% 21.4% 6.0% 20.4% 20.4%   Credit score (0-100)   0 0 20 19 4 39 5 5   Credit rating   N/A N/A BB BB B BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 554 126 462 6,061 0.0 0.0   EBITDA   0.0 0.0 448 -185 -2,109 1,679 0.0 0.0   EBIT   0.0 0.0 445 -228 -2,343 1,119 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 434.5 -235.0 -2,413.0 906.3 0.0 0.0   Net earnings   0.0 0.0 334.9 -192.0 -1,967.0 693.3 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 435 -235 -2,413 906 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 194 375 1,692 1,680 0.0 0.0   Shareholders equity total   0.0 0.0 375 183 -704 -10.3 -187 -187   Interest-bearing liabilities   0.0 0.0 0.0 0.0 3,286 3,215 187 187   Balance sheet total (assets)   0.0 0.0 991 959 5,445 6,424 0.0 0.0   Net Debt   0.0 0.0 -660 -12.0 3,244 3,190 187 187     See the entire balance sheet 1000.0 Volume  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 554 126 462 6,061 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% -77.3% 266.7% 1,211.9% -100.0% 0.0%   Employees   0 0 1 1 2 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% 150.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 991 959 5,445 6,424 0 0   Balance sheet change%   0.0% 0.0% 0.0% -3.2% 467.8% 18.0% -100.0% 0.0%   Added value   0.0 0.0 448.5 -185.0 -2,300.0 1,678.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 190 138 1,083 -409 -1,842 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 80.2% -181.0% -507.1% 18.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 44.9% -23.4% -65.8% 17.9% 0.0% 0.0%   ROI %   0.0% 0.0% 117.5% -81.2% -134.7% 34.7% 0.0% 0.0%   ROE %   0.0% 0.0% 89.3% -68.8% -69.9% 11.7% 0.0% 0.0%   1000.0 Solidity  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   0.0% 0.0% 37.8% 19.1% -11.4% -0.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -147.2% 6.5% -153.8% 190.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% -466.8% -31,163.5% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 4.6% 6.8% 0.0% 0.0%   1000.0 Liquidity  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.0 1.1 0.5 0.5 0.5 0.0 0.0   Current Ratio   0.0 0.0 1.1 0.5 0.5 0.5 0.0 0.0   Cash and cash equivalent   0.0 0.0 660.2 12.0 42.0 25.9 0.0 0.0   1000.0 Capital use efficiency  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 71.8 -385.0 -2,536.0 -2,535.9 -93.5 -93.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 448 -185 -1,150 336 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 448 -185 -1,055 336 0 0   EBIT / employee   0 0 445 -228 -1,172 224 0 0   Net earnings / employee   0 0 335 -192 -984 139 0 0